- A Case of Aplastic Anemia Associated with Ticlopidine
-
Lee JY, Shin HE, Kim JS, Lee KS
- KMID: 2256027
- Korean J Cerebrovasc Dis.
- 2001 Mar;3(1):81-82.
Aplastic anemia is a rare side-effect associated with ticlopidine therapy. We report one case of severe aplastic anemia developed after the use of ticlopidine. A 72-year-old woman took ticlopidine at... -
- CITED
-
- Close
- SHARE
-
- Close
- Two cases of pancytopenia induced by ticlopidine
-
Park CY, Kang JE, Yim HS, Chung CH
- KMID: 2252759
- Korean J Med.
- 2003 Nov;65(Suppl 3):S841-S843.
Ticlopidine is an inhibitor of platelet aggregation used in the management and prevention of thromboembolic disorders. Hematological toxicity is one of the most important side effects of ticlopidine, including neutropenia,... -
- CITED
-
- Close
- SHARE
-
- Close
- Three Cases of Ticlopidine-induced Cholestatic Hepatitis
-
Kim JH, Kwon YJ, Kim JE, Woo KE, Kim YJ
- KMID: 2343006
- J Korean Neurol Assoc.
- 2002 Jul;20(4):434-436.
Ticlopidine hydrochloride is world-wide used antiplatelet agent that inhibit ADP pathway. Its clinical side effects are the change of the blood picture, allergic skin reaction and gastrointestinal symptoms. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Ticlopidine-Induced Cholastatic Jaundice
-
Woo KE, Cho HK, Shin GJ
- KMID: 1964769
- Ewha Med J.
- 1997 Jun;20(2):145-149.
- doi: 10.12771/emj.1997.20.2.145
Ticlopidine, a platelet aggregation inhibitor, is widely used in the secondary prevention of stroke and previous manifestation of peripheral arterial occlusive disease, Ticlopidine is also used to prevent myocardial infarction... -
- CITED
-
- Close
- SHARE
-
- Close
- Four cases of ticlopidine-induced cholestatic hepatitis
-
Han J, Kim MH, Moon HK, Kang KT, Cha KS, Kim YD, Kim JS
- KMID: 1985130
- Korean J Med.
- 2002 Nov;63(5):557-561.
Ticlopidine, a potent antiplatelet agent, is widely used for treatment of coronary artery disease and cerebrovascular disease. Adverse effects has been reported in 10% to 20% of patients receiving ticlopidine.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine
-
Bae MC, Kim JW, Jang EA, Huh K
- KMID: 2342847
- J Korean Neurol Assoc.
- 2000 Jul;18(4):512-514.
Ticlopidine, a widely used antiplatelet agent, has been rarely reported to cause thrombotic thrombocytopenic purpura (TTP). To the best of our knowledge, its occurrence has never before been reported in... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Cholestatic Jaundice and Subsequent Pancytopenia Associated with Ticlopidine
-
Yoon HS, Kim HK, Cha KS, Yoon UD, Ji SY, Kim JH, Joo SB, Kim MH, Kim YD, Shin WW, Kim JS
- KMID: 1968303
- Korean Circ J.
- 1999 Nov;29(11):1259-1263.
- doi: 10.4070/kcj.1999.29.11.1259
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Severe Neutropenia Associated with Ticlopidine
-
Kim JT, Lee JG, Seo CJ, Shin EK
- KMID: 2434663
- Korean Circ J.
- 1999 Jul;29(7):746-750.
Ticlopidine is a powerful inhibitor of platelet aggregation which is induced by adenosine diphosphate. Ticlopidine has been shown to be effective in reducing combined stroke, myocardial infarction, reocclusion of coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe aplastic anemia induced by ticlopidine: report of two cases
-
Bahng H, Lee JH, Suh C, Ahn JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS, Kim SH
- KMID: 645216
- J Korean Med Sci.
- 1998 Oct;13(5):541-544.
- doi: 10.3346/jkms.1998.13.5.541
Aplastic anemia is a rare side-effect associated with ticlopidine therapy. We report two cases of severe aplastic anemia developed after the use of ticlopidine. A 51-year-old woman took ticlopidine... -
- CITED
-
- Close
- SHARE
-
- Close
- The Inhibitory Effect of Ticlopidine on VEGF Induced Corneal Neovascularization
-
Park YK, Kim MY, Bae SR
- KMID: 2022140
- J Korean Ophthalmol Soc.
- 2003 Jun;44(6):1392-1396.
PURPOSE: Ticlopidine, which has platelet inhibitory property, is currently used in peripheral arterial obstructive disease, ischemic stroke, and coronary artery disease. It is also known to have antiangiogenesis effect. We... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Ticlopidine-induced Neutropeina Treated with rhG-CSF
-
Lee SG, Ahn CW, Kim HS, Rim S, Cho SY, Min YH
- KMID: 1894759
- Korean Circ J.
- 1998 Jan;28(1):118-122.
- doi: 10.4070/kcj.1998.28.1.118
There are many conditions which are associated with neutropenia, such as infections, chemical and physical agents, and hematopoietic diseases. But ticlopidine-induced neutropenis is rarely reported in Korea. We experienced a... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Study on the Antiplatelet Aggregation Effect of Ticlopidine Hydrochloride(Ticlid(R))
-
Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW
- KMID: 1668797
- Korean Circ J.
- 1986 Sep;16(3):379-387.
- doi: 10.4070/kcj.1986.16.3.379
The antiplatelet aggregation effect of ticlopidine was studied in 22 cases of coronary artery disease(CAD) and 17 cases of control by obseving changes of plarma beta-thromboglobulin(beta-TG) and platelet factor 4(PF-4)... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Antiplatelet Aggregation Effect between the High-Dose and Low-Dose Ticlopidine: A Preliminary Study
-
Kim JM, Kim J, Song HJ, Lee HB, Lee TY
- KMID: 1812889
- J Korean Neurol Assoc.
- 1999 May;17(3):347-351.
BACKGROUND: To investigate the efficacy of antiplatelet activity of low dose ticlopidine, we compared the antiplatelet effect of low dose ticlopidine with a high dose. METHODS: Fourteen healthy volunteers were... -
- CITED
-
- Close
- SHARE
-
- Close
- Strategy for the Treatment of Clopidogrel Low Responsiveness in Diabetes Mellitus and Stent Implantation
-
Kim JY
- KMID: 2225647
- Korean Circ J.
- 2009 Nov;39(11):459-461.
- doi: 10.4070/kcj.2009.39.11.459
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two cases of Ticlopidine-induced neutropenia in patients with cardiovascular disease
-
Chae GS, Yoo HS, Jee JH, Lee JM, Ahn JS, Lee JA, Park YS, Doo YC, Han KR, Oh DJ, Rhim CY
- KMID: 2228923
- Korean Circ J.
- 1998 Feb;28(2):280-283.
- doi: 10.4070/kcj.1998.28.2.280
Ticlopidine is an antiplatelet agent used as a drug to prevent the recurrence of cerebral infarction or ischemic heart disease. Close attention has recently been paid to the superiority of... -
- CITED
-
- Close
- SHARE
-
- Close
- Spontaneous Multi-Stage Gluteus Muscular Hemorrhage Following Long-Term Use of Clopidogrel
-
Lee MJ, Lee DK
- KMID: 1966500
- J Korean Neurol Assoc.
- 2011 Nov;29(4):406-406.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Compartment Syndrome Following an Olecranon Fracture in a Stroke Patient Taking Ticlopidine and Aspirin
-
Lee S, Oh SC, Bae SY
- KMID: 2323444
- J Korean Soc Surg Hand.
- 2011 Dec;16(4):255-258.
We report a case of compartment syndrome following an olecranon fracture in the stroke patient with quadriparesis taking ticlopidine and aspirin. Antithrombic and antiaggregating ability of the medications could increase... -
- CITED
-
- Close
- SHARE
-
- Close
- The Inhibitory Effect of Ticlopidine to Platelet Aggregation
-
Yu KH, Lee BC, Kwon KH, Kim SY, Song HK, Kim SM
- KMID: 2342435
- J Korean Neurol Assoc.
- 1994 Sep;12(3):436-443.
Ticlopidine is widely used as an anti-platelet agent and taken by the patients with thrombotic occlusive vascular disease. The aim of this study was to investigate the alterations in platelet... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative study of triflusal and ticlopidine on anti-platelet aggregatory effect and side effects
-
Kim HG, Kim JS, Lee MC
- KMID: 1546747
- J Korean Neurol Assoc.
- 1998 Feb;16(1):21-27.
BACKGROUND AND PURPOSE: Platelet aggregation plays an important role in thrombogenesis. Thus antiplatelet agents, such as aspirin and ticlopidine, have been in usage to prevent for recurrent ischemic stroke. Triflusal... -
- CITED
-
- Close
- SHARE
-
- Close
- Ticlopidine Induced Bullous Pemphigoid
-
Lee HY, Baek JO, Lee JR, Kim M, Kim SC, Roh JY
- KMID: 2247764
- Korean J Dermatol.
- 2009 Sep;47(9):1019-1023.
Bullous pemphigoid (BP) is an acquired autoimmune disease that's characterized by subepidermal vesicles and bullae. The etiology for BP is mostly idiopathic, but numerous observations have suggested the role of... -
- CITED
-
- Close
- SHARE
-
- Close
